- What Pass-Rate Data Actually Exists for Neuromuscular Medicine
- Reading the 6-for-6 October 2024 Cohort Correctly
- Why the Exam Has No Fixed Pass-Rate Quota
- Who Sits for the Exam and Why That Shapes Outcomes
- Where the Blueprint Concentrates Risk
- Format and Timing Pressures That Affect Performance
- Turning Blueprint Weights Into a Preparation Plan
- What an Attempt Costs and Why It Matters
- After You Pass: Continuing Certification
- Frequently Asked Questions
- ABPMR's October 2024 first-time cohort had six candidates and six passes, a very small sample, not a predictor.
- Passing means meeting a performance standard on total score; there is no fixed pass-rate quota.
- Peripheral nerve and Muscle disorders are each 24-26% of questions; Clinical aspects of neurologic disease is 35-41%.
- The 2026 sitting is October 19-23; on-time cost is $2,000 ($1,400 exam plus $600 processing).
What Pass-Rate Data Actually Exists for Neuromuscular Medicine
Candidates searching for a Neuromuscular Medicine pass rate usually want one number: the percentage of people who pass. For this subspecialty, that number is thinner than for large primary certifications, and an honest article has to say so up front. Neuromuscular Medicine (NMM) is a small-volume subspecialty examination, offered for initial certification only every other year, with a candidate pool drawn from a narrow group of fellowship graduates.
The only concrete figure available for this guide comes from the issuer. The American Board of Physical Medicine & Rehabilitation (ABPMR) reports that its October 2024 first-time initial-certification cohort for Neuromuscular Medicine had six candidates and six passes, or 100%. That is a real data point, and it is also a very small one. It is specific to ABPMR-route candidates, it does not describe every candidate who has ever sat for the examination, and it says nothing about what will happen to any individual in 2026.
If you are still deciding whether this credential is worth pursuing, pair this data discussion with the broader NMM difficulty guide and the ROI analysis for the certification.
Reading the 6-for-6 October 2024 Cohort Correctly
A 100% pass rate sounds reassuring, but statistics on six people carry almost no predictive weight. A single additional failure would have moved the figure to roughly 86%, and a cohort this size cannot distinguish between an easy examination, a well-prepared group, or ordinary chance. Treat it the way you would treat a case series in a journal: interesting, hypothesis-generating, and not a basis for a firm conclusion.
There is also a selection effect worth understanding. To sit for the exam through the ABPMR route, a candidate must already hold primary ABPMR certification in good standing and must have completed a 12-month ACGME-accredited post-residency neuromuscular medicine fellowship. These are people who have already cleared a primary board examination and a year of focused subspecialty training. High pass rates among a pre-filtered group are unsurprising, but they do not transfer to someone who is underprepared in a heavily weighted domain.
Why the Exam Has No Fixed Pass-Rate Quota
A common misunderstanding is that boards fail a set percentage of candidates. For Neuromuscular Medicine, passing requires meeting an acceptable performance standard on total score. The pass rate is an outcome of how a given group performs against that standard, not a target the board is aiming for. If an entire cohort meets the standard, the entire cohort passes, which is consistent with a result like six of six.
Several scoring features are worth knowing:
- Total-score standard: The decision rests on overall performance, not on passing each section or each domain separately.
- Research/pretest items are excluded: Some questions may be unscored items under evaluation. You cannot tell which, so treat every question seriously.
- No guessing penalty: Answer every question. An unanswered item can only cost you.
- No numeric cut score published here: This guide does not supply a fixed passing score, and you should be wary of any source quoting one without citing the board. For a fuller treatment, see NMM passing score: what you need to pass.
Who Sits for the Exam and Why That Shapes Outcomes
The examination is developed, administered, and scored by the American Board of Psychiatry and Neurology (ABPN) as a shared initial subspecialty examination, delivered at Pearson Professional Centers. ABPMR remains the selected certifying issuer for physiatrists pursuing this credential. That split matters when you read pass-rate claims: the scoring body and the certifying body are different organizations, and statistics published by the issuer describe its own candidates.
For the ABPMR route, eligibility consists of:
- Primary ABPMR certification in good standing.
- An unrestricted medical license in the US, a US territory, or Canada.
- A 12-month ACGME-accredited post-residency neuromuscular medicine fellowship, including at least six months of direct clinical care, completed by August 31 before the examination.
- A recommendation from the fellowship program director.
Do not substitute the ABPN's own applicant-route rules for the ABPMR requirements above; they are separate pathways with their own conditions. Our NMM requirements guide walks through qualification in more detail.
Where the Blueprint Concentrates Risk
Because a pass hinges on total score, the most useful "data" for a candidate is the content blueprint, which tells you where points are concentrated. The ABPN content specifications (December 1, 2025) classify every question on two intersecting axes. The percentages within each axis describe different slicings of the same questions, so they should not be added together across axes.
Axis 1: Neuromuscular disorders and topics
| Disorder area | Official range |
|---|---|
| Motor neuron disorders | 15-18% |
| Spinal root disorders | 4-6% |
| Plexopathies | 4-6% |
| Peripheral nerve disorders | 24-26% |
| Neuromuscular junction transmission disorders | 16-20% |
| Muscle disorders | 24-26% |
| Hyper-excitability disorders | 1-3% |
| Autonomic dysfunction in neuromuscular diseases | 1-3% |
| Questions not associated with a specific neuromuscular disorder | 1-2% |
Axis 2: Physician competencies and mechanisms
| Competency area | Official range |
|---|---|
| Neuroscience and mechanism of disease | 7-13% |
| Clinical aspects of neurologic disease | 35-41% |
| Diagnostic procedures | 21-27% |
| Treatment/management | 17-23% |
| Interpersonal and communication skills | 1-3% |
| Professionalism | 1-3% |
| Practice-based learning and improvement | 1-3% |
| Systems-based practice | 1-3% |
Peripheral nerve disorders (24-26%) and Muscle disorders (24-26%)
These two areas are joint largest on the disorder axis, together accounting for roughly half of all questions by range. A weakness here is the most expensive weakness you can have.
- Expect questions that link clinical presentation, electrodiagnostic findings, and management in a single stem.
- Know how neuropathies and myopathies differ in pattern, not just in name.
- Be ready to move between the bedside picture and the laboratory or neurophysiology picture.
Neuromuscular junction transmission disorders (16-20%) and Motor neuron disorders (15-18%)
These are the next tier. Together they represent a substantial share of the disorder axis and reward careful differentiation of look-alike conditions.
- Distinguish presynaptic from postsynaptic patterns and know which tests separate them.
- For motor neuron disease, practice distinguishing mimics and understanding management priorities.
The small areas deserve a brief mention, not neglect. Spinal root disorders and plexopathies are each 4-6%, while hyper-excitability and autonomic dysfunction are each 1-3%. Because they are compact, they are efficient to review late in your preparation, but they should not consume early weeks that belong to the large areas.
Format and Timing Pressures That Affect Performance
The initial examination consists of 220 one-best-answer multiple-choice questions, delivered in four sections of 55 questions. The administrator's format-and-scoring document (updated November 30, 2023) specifies 230 minutes for questions and optional inter-section breaks, plus five minutes for the nondisclosure agreement and tutorial and five minutes for a survey, totaling a four-hour appointment.
One discrepancy deserves candor. ABPMR's overview describes a single four-hour section with four hours of active testing plus tutorial, which differs from the detailed administrator timer described above. Rather than guess which description governs your sitting, read the admission instructions you receive and plan around those. Our exam dates and scheduling guide covers logistics in more detail.
Testing is closed book and in-person proctored. Personal electronics and study materials are prohibited, and two valid signed IDs are required, including one government-issued photo ID. Sort out your identification well before test day so an administrative problem does not become a performance problem.
Turning Blueprint Weights Into a Preparation Plan
Since the pass decision is made on total score, your preparation should mirror where the points are. A sensible allocation front-loads the largest areas and reserves the final stretch for integration and the small domains. The sketch below is illustrative, tied to the blueprint, and should be adjusted to your own gaps. For a fuller plan, see the NMM study guide.
Peripheral nerve and muscle disorders
- Cover the two joint-largest disorder areas first.
- Pair each condition with its diagnostic procedure findings and treatment approach.
Neuromuscular junction and motor neuron disorders
- Build side-by-side comparisons of look-alike conditions.
- Review management priorities for each.
Roots, plexus, hyper-excitability, autonomic
- Sweep the small areas efficiently.
- Link anatomy to localization reasoning.
Mixed practice and weak-spot repair
- Take full-length question blocks under timed conditions.
- Review the competency domains: neuroscience, diagnostics, treatment, and the four small professionalism-type areas.
Key Takeaway
Because Clinical aspects of neurologic disease is the largest competency area (35-41%) and Diagnostic procedures follows at 21-27%, practice questions that force you to reason from presentation to test choice to management. Memorizing isolated facts under-serves you on a one-best-answer format. Use timed practice questions to find where your reasoning breaks down.
What an Attempt Costs and Why It Matters
The 2026 ABPMR fee is $1,400 for the examination plus $600 in processing, for a total of $2,000 when you apply on time. Late applications add $500. The examination is offered for initial testing only every other year, with the 2026 dates set for October 19-23. A missed deadline or a failed attempt therefore carries a larger scheduling cost than it would for an annually offered test, which is a practical reason to treat the pass rate as a reason for caution rather than complacency.
| Item | Amount |
|---|---|
| Examination fee | $1,400 |
| Processing fee | $600 |
| Total, on time | $2,000 |
| Late application surcharge | +$500 |
For a broader look at expenses, see the NMM certification cost breakdown.
After You Pass: Continuing Certification
Passing the initial examination is the start of a maintenance cycle, not the end of one. Continuing certification (CC) requires professionalism and licensure, lifelong learning, quality improvement, and a separate subspecialty assessment. Non-assessment requirements have reciprocity with your primary ABPMR certification, which reduces duplication.
- Annual CC program fee: $360.
- CME: an average of 30 Category 1 credits annually, totaling 150 per five-year cycle.
- Self-assessment: the SA-CME requirement was reduced from 50 to 48 credits per five-year cycle effective August 18, 2026. This newer announcement supersedes the older 50-credit figure that still appears in some timeline articles.
- Quality improvement: one Improving Health and Health Care (IHHC) project per five-year cycle.
On August 12, 2026, ABPMR announced an Article-Based Continuing Certification (ABCC) pathway for Neuromuscular Medicine beginning in 2027. That future maintenance pathway, and the separate 150-question CC examination, do not replace the initial-certification examination you are preparing for in 2026. Keep the two tracks distinct in your planning. If you are weighing career value, the salary analysis and NMM jobs overview are useful next reads.
Frequently Asked Questions
The only figure supplied here is ABPMR's October 2024 first-time initial-certification cohort: six candidates and six passes, or 100%. That cohort is very small and specific to the ABPMR route, so it is not an ABPN-wide or all-candidate pass rate and does not predict an individual outcome.
No. Passing requires meeting an acceptable performance standard on total score, not a quota. Research and pretest items are excluded from scoring, and guessing is not penalized, so you should answer every question.
Start with Peripheral nerve disorders and Muscle disorders, each 24-26% of questions, then Neuromuscular junction transmission disorders (16-20%) and Motor neuron disorders (15-18%). On the competency axis, Clinical aspects of neurologic disease is largest at 35-41%. Remember the two axes overlap and should not be added together.
There are 220 one-best-answer multiple-choice questions in four sections of 55. The administrator document specifies 230 minutes for questions and optional breaks, within a four-hour appointment. ABPMR's overview describes the timing differently, so confirm the instructions for your sitting.
The 2026 examination window is October 19-23, and initial testing is offered every other year. The on-time cost through ABPMR is $2,000 ($1,400 plus $600 processing), with a $500 late surcharge. More detail is in our exam dates guide.